Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: galt who wrote (63088)	4/16/2025 4:26:50 PM
From: jargonweary	4 Recommendations Recommended By erippetoe Fitzhughlaw jhcimmu urslor Respond to of 63285

The comparisons with IMMU seem to me to be only superficial. IMMU had a founder and CEO (via his wife) who was selfish, rapacious, arrogant and stubborn. But he did not control enough shares to fight off a hostile takeover focused on shareholder value versus his control of the company. With IBRX one person calls the shots and there is no credible possibility of ever removing him or his absolute control over the company. I knew this when I invested but what I didn’t know but what I have come to wonder is whether the man is, to use the technical, medical term: barking mad. Now I have to decide whether I hang on while he appears to be losing his focus on IBRX or just cut my losses at some point. Guess I should have put my money in safe, US Treasuries. Oh, wait….they are cratering now, too!